Regents Of The University Of California Erasca, Inc. Transaction History
Regents Of The University Of California
- $179 Million
- Q2 2024
A detailed history of Regents Of The University Of California transactions in Erasca, Inc. stock. As of the latest transaction made, Regents Of The University Of California holds 236,236 shares of ERAS stock, worth $677,997. This represents 0.31% of its overall portfolio holdings.
Number of Shares
236,236
Previous 236,236
-0.0%
Holding current value
$677,997
Previous $486,000
14.61%
% of portfolio
0.31%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding ERAS
# of Institutions
135Shares Held
205MCall Options Held
3.1KPut Options Held
142K-
Vr Adviser, LLC New York, NY16.2MShares$46.5 Million4.2% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA16.2MShares$46.5 Million2.26% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$39.5 Million1.36% of portfolio
-
Arch Venture Management, LLC Chicago, IL11.1MShares$31.7 Million15.29% of portfolio
-
Black Rock Inc. New York, NY10.6MShares$30.5 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $351M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...